Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 6/2014

Open Access 01-12-2014 | Commentary

Prehospital treatment of sepsis: what really makes the “golden hour” golden?

Authors: Sarah A Sterling, Michael A Puskarich, Alan E Jones

Published in: Critical Care | Issue 6/2014

Login to get access

Abstract

The early recognition of severe sepsis is important; however, early identification of severe sepsis can be challenging, especially in the prehospital setting. As previous research has shown, advanced notification of time-sensitive disease states by prehospital personnel can improve outcomes and time to initiation of treatments. Prehospital personnel can potentially impact outcomes in sepsis through early identification and treatment implementations, improving processes of care and transition of care. Further research is needed for a full evaluation of prehospital treatment effects of identification of sepsis and treatment by prehospital personnel and the impact on outcomes.
Literature
1.
Seymour CW, Cooke CR, Heckbert SR, Spertus JA, Callaway CW, Martin-Gill C, Yealy DM, Rea TD, Angus DC: Prehospital intravenous access and fluid resuscitation in severe sepsis: an observational cohort study. Crit Care. 2014, 18: 533-10.1186/s13054-014-0533-x.CrossRef
2.
Angus DC, van der Poll T: Severe sepsis and septic shock. N Engl J Med. 2013, 369: 2063-10.1056/NEJMra1208623.CrossRef
3.
Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J: Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008, 358: 111-124. 10.1056/NEJMoa071366.CrossRef
4.
Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, Gardlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD: Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012, 366: 2055-2064. 10.1056/NEJMoa1202290.CrossRef
5.
Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F, Terndrup T, Wang HE, Hou PC, LoVecchio F, Filbin MR, Shapiro NI, Angus DC: A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014, 370: 1683-1693. 10.1056/NEJMoa1401602.CrossRef
6.
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013, 41: 580-637. 10.1097/CCM.0b013e31827e83af.CrossRef
7.
Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC: The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med. 2010, 38: 367-374. 10.1097/CCM.0b013e3181cb0cdc.CrossRef
8.
Klein Klouwenberg PM, Ong DS, Bonten MJ, Cremer OL: Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria. Intensive Care Med. 2012, 38: 811-819. 10.1007/s00134-012-2549-5.CrossRef
9.
Guerra WF, Mayfield TR, Meyers MS, Clouatre AE, Riccio JC: Early detection and treatment of patients with severe sepsis by prehospital personnel. J Emerg Med. 2013, 44: 1116-1125. 10.1016/j.jemermed.2012.11.003.CrossRef
10.
Nam J, Caners K, Bowen JM, Welsford M, O’Reilly D: Systematic review and meta-analysis of the benefits of out-of-hospital 12-lead ECG and advance notification in ST-segment elevation myocardial infarction patients. Ann Emerg Med. 2014, 64: 176-186. 10.1016/j.annemergmed.2013.11.016.CrossRef
11.
Abdullah AR, Smith EE, Biddinger PD, Kalenderian D, Schwamm LH: Advance hospital notification by EMS in acute stroke is associated with shorter door-to-computed tomography time and increased likelihood of administration of tissue-plasminogen activator. Prehosp Emerg Care. 2008, 12: 426-431. 10.1080/10903120802290828.CrossRef
12.
Studnek JR, Artho MR, Garner CL, Jones AE: The impact of emergency medical services on the ED care of severe sepsis. Am J Emerg Med. 2012, 30: 51-56. 10.1016/j.ajem.2010.09.015.CrossRef
Metadata
Title
Prehospital treatment of sepsis: what really makes the “golden hour” golden?
Authors
Sarah A Sterling
Michael A Puskarich
Alan E Jones
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Critical Care / Issue 6/2014
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-014-0697-4

Other articles of this Issue 6/2014

Critical Care 6/2014 Go to the issue

Research

Fluid balance, intradialytic hypotension, and outcomes in critically ill patients undergoing renal replacement therapy: a cohort study

Research

Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial

Research

The protective effects of a phosphodiesterase 5 inhibitor, sildenafil, on postresuscitation cardiac dysfunction of cardiac arrest: metabolic evidence from microdialysis

Research

Levosimendan attenuates multiple organ injury and improves survival in peritonitis-induced septic shock: studies in a rat model

Commentary

Biomarkers for acute kidney injury: is NGAL ready for clinical use?

Research

Genetic variation in the tissue factor gene is associated with clinical outcome in severe sepsis patients